This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2003 Aug 1;98(3):437-57.

doi: 10.1002/cncr.11520.

Chronic myelogenous leukemia: a review and update of therapeutic strategies

Guillermo Garcia-Manero¹, Stefan Faderl, Susan O'Brien, Jorge Cortes, Moshe Talpaz, Hagop M Kantarjian

Affiliations

PMID: 12879460
DOI: 10.1002/cncr.11520

Free article

Review

Chronic myelogenous leukemia: a review and update of therapeutic strategies

Guillermo Garcia-Manero et al. Cancer. 2003.

Free article

. 2003 Aug 1;98(3):437-57.

doi: 10.1002/cncr.11520.

Authors

Guillermo Garcia-Manero¹, Stefan Faderl, Susan O'Brien, Jorge Cortes, Moshe Talpaz, Hagop M Kantarjian

Affiliation

¹ Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, Texas. hkantarj@mdanderson.org

PMID: 12879460
DOI: 10.1002/cncr.11520

No abstract available

PubMed Disclaimer

Similar articles

Chronic myelogenous leukemia--update and future directions.
Kantarjian HM, Deisseroth A, Talpaz M. Kantarjian HM, et al. Rev Invest Clin. 1994 Apr;Suppl:118-24. Rev Invest Clin. 1994. PMID: 7886295 Review. No abstract available.
NCCN Practice Guidelines for Chronic Myelogenous Leukemia.
Berman E, Clift RA, Copelan EA, Emanuel PD, Erba HP, Glenn MJ, Greenberg PL, Jones RJ, O'Brien S, Saba HI, Schilder R, Snyder DS, Soiffer RJ, Tallman MS, Wetzler M, Ravandi-Kashani F, Kantarjian H, Talpaz M; National Comprehensive Cancer Network. Berman E, et al. Oncology (Williston Park). 2000 Nov;14(11A):229-40. Oncology (Williston Park). 2000. PMID: 11195415 No abstract available.
[Treatment of chronic myeloid leukemia].
Guilhot F. Guilhot F. Nouv Rev Fr Hematol (1978). 1993 Jun;35(3):151-4. Nouv Rev Fr Hematol (1978). 1993. PMID: 7687766 Review. French. No abstract available.
Current controversies on the role of interferon-alpha for therapy of chronic myeloid leukemia.
Heimpel H, Allan NC, Baccarani M, Guilhot F, Hehlmann R, Horowitz M, Kluin-Nelemans J, Schaefer U, Storb R, Thaler J. Heimpel H, et al. Bone Marrow Transplant. 1996 May;17 Suppl 3:S39. Bone Marrow Transplant. 1996. PMID: 8769699 No abstract available.
[Therapy of chronic myeloid leukemia].
Freund M. Freund M. Internist (Berl). 1993 Jun;34(6):542-9. Internist (Berl). 1993. PMID: 8335444 Review. German. No abstract available.

See all similar articles

Cited by

Massive subcutaneous bleeding as a first manifestation of chronic myeloid leukemia in chronic phase.
Nacinovic AD, Miletic B, Topljak-Polic D, Balen S, Stimac D. Nacinovic AD, et al. Wien Klin Wochenschr. 2004 Aug 31;116(15-16):523. doi: 10.1007/BF03217704. Wien Klin Wochenschr. 2004. PMID: 15471178 No abstract available.
Imatinib adherence associated clinical outcomes of chronic myeloid leukaemia treatment in Taiwan.
Chen TC, Chen LC, Huang YB, Chang CS. Chen TC, et al. Int J Clin Pharm. 2014 Feb;36(1):172-81. doi: 10.1007/s11096-013-9876-7. Epub 2013 Nov 19. Int J Clin Pharm. 2014. PMID: 24242992 Free PMC article.
Optimal treatment strategy with nilotinib for patients with newly diagnosed chronic-phase chronic myeloid leukemia based on early achievement of deep molecular response (MR^4.5 ): The phase 2, multicenter N-Road study.
Nishiwaki K, Sugimoto KJ, Tamaki S, Hisatake J, Yokoyama H, Igarashi T, Shinagawa A, Sugawara T, Hara S, Fujikawa K, Shimizu S, Yujiri T, Tojo A, Wakita H. Nishiwaki K, et al. Cancer Med. 2020 Jun;9(11):3742-3751. doi: 10.1002/cam4.3034. Epub 2020 Apr 6. Cancer Med. 2020. PMID: 32253827 Free PMC article. Clinical Trial.
Pathways to Genome-targeted Therapies in Serous Ovarian Cancer.
Axelrod J, Delaney J. Axelrod J, et al. J Nat Sci. 2017 Jul;3(7):e408. J Nat Sci. 2017. PMID: 28815209 Free PMC article.
New Genetic Variation in BCR gene of Major B3a2 Breakpoint BCR-ABL Fusion Gene in Patients with Chronic Myelogenous Leukemia in Yogyakarta, Indonesia.
Sholikah TA, Hutajulu SH, Sulistyawati D, Aning S, Fatmawati S, Syifarahmah A, Widayati K, Kurnianda J, Paramita DK. Sholikah TA, et al. Asian Pac J Cancer Prev. 2017 May 1;18(5):1343-1348. doi: 10.22034/APJCP.2017.18.5.1343. Asian Pac J Cancer Prev. 2017. PMID: 28612580 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Wiley
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information